Roche receives FDA approval for HER2 tests in gastric cancers

Markets Investing.com By Investing.com 26 Aug 2026 18:56 1 min read
Roche receives FDA approval for HER2 tests in gastric cancers

Covered in this story

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.